Search Results

1 - 10 of 3,540 items :

  • "screening" x
Clear All

populacyjnego programu wczesnego wykrywania raka piersi wśród kobiet w Polsce. Pielęg Pol. 2013; 1(47): 18‑22. 13. Dyzmann-Sroka A, Jędrzejczak A, Trojanowski M, Kubiak A. Przyczyny niskiej zgłaszalności Polek na badania profilaktyczne. Zeszyty naukowe WCO. 2010; 1(7): 17-27. 14. Zatoński W. Europejski kodeks walki z rakiem. Warszawa: Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie; 2009, p. 17-95. 15. Wender R. Barriers to screening for colorectal cancer. Gastrointest Endosc Clin N Am. 2002; 12(1): 145-70. 16. Godlewski D, Michalak J, Schroeiber T. Projektowanie

of Diabetes in the World, 2013 Available from: prevalence-diabetes-world-2013 4. Aiello LM et al. Diabetic retinopathy. In: Guyer, Yannuzzi, Chang, Shields, Green editors. Retina- Vitreous-Macula. Philadelphia: WB Saunders Co, 1999. p. 316-44. 5. Wykoff CC, Brown DM. Medscape Ophthalmology: Diabetic Retinopathy: A Team Approach to Screening, Referral, and Treatment. Disclosures Mar 20, 2012. Available from: 6. Chakrabarti R, Harper CA, Keefe E. Diabetic Retinopathy

papillomavirus prevalence surveys. Cancer Epidemiol Biomarkers Prev 2006; 15 (2): 326-33. 5. Ilardi M, Shikova E et al. D3 - Analyza miestnych suvislosti [CD-ROM]. Projekt AURORA; 2012. 6. Institute for Statistical and Epidemiological Cancer Research: Finnish Cancer Registry [online]. 2010 [cit. 2014-08-12]. Available at: 7. ICO Information Centre on HPV and Cancer: Data Query [online]. 2014 [cit. 2014-08-12]. Available at: http

-related treatments, placing Malaysia among the countries in Southeast Asia with the highest proportion spent on diabetes-related treatments resulting in significant economic burden [ 7 ]. Diabetes is often asymptomatic and is induced mostly by an unhealthy lifestyle rather than genetic factors [ 9 ]. It is widely documented that an early detection of the symptoms can lower the risk of diabetes if followed by proper interventions [ 9 ]. Blood glucose screening can help to identify individuals who are at high risk of diabetes when the chances of preventing it are high [ 9 ]. Despite

References [1] Burgard P, Rupp K, Lindner M, Haege G, Rigter T, Weinreich SS, Loeber JG, Taruscio D, Vittozzi L, Cornel MC, Hofmann GF. Newborn screening programmes in Europe; arguments and eforts regarding harmonization. Part 2 - From screening laboratory results to treatment, follow-up and quality assurance. J Inherit Metab Dis. 2012;35: 613-25. [2] Dluholucký S, Knapková M, Záhorcová M. Newborn screening in Slovakia - from 1985 till today. Acta Fac Pharm Univ Comen 2013, Suppl.VIII:32-36 Available at

References Anonymous (2009). Cystic fibrosis transmembrane conductance regulator. [PUBMED] Bobadilla, J., L., Farrell, M.H., Farrell, P.M. (2002). Applying CFTR molecular genetics to facilitate the diagnosis of cystic fibrosis through screening. Adv. Pediatr. , 49 , 131-190. Corbetta, C., Seia, M., Bassotti, A., Ambrosioni, A., Giunta, A., Padoan, R. (2002). Screening for cystic fibrosis in newborn infants: Results of a pilot programme based on a two tier protocol (IRT/DNA/IRT) in the Italian population. J. Med. Screen , 60-63. Ferec, C., Casals, T

REFERENCES 1. Asma R, Mejda Daami R, Faten O, Afef L, Imen R, Rabiaa H. Assessment of the antifungal activity of Nicotiana glauca Graham aqueous and organic extracts against some pathogenic and antagonistic fungi. Afr J Microbiol Res . 2012;6:4655-61. 2. Zaid N, Khaled ME, Eman K, Nouha F. Phytochemical screening and heavy metals contents of Nicotiana glauca plant. Ijppr Human . 2015;4:82-91. 3. Ntelios D, Kargakis M, Topalis T, Drouzas A, Potolidis E. Acute respiratory failure due to Nicotiana glauca ingestion. Hippokratia . 2013;2:183-4. 4. Ashenafi A

microalbuminuria in type 2 diabetes mellitus patients. J Med Assoc Thai. 2011; 94 Suppl 2:S6-10. 9. Lepore G, Maglio ML, Nosari I, Dodesini AR, Trevisan R. Cost-effectiveness of two screening programs for microalbuminuria in type 2 diabetes. Diabetes Care. 2002; 25:2103-4. 10. United Nation Thailand. Thailand Info [internet] 2010 [cited 2011 Jun 18]. Available from: 11. National Health Security Office. Annual report of Thai Universal Health Coverage Scheme 2009. Bangkok: Sahamitr Printing and Publishing; 2010. 12. Zhang AH, Cheng LT, Zhu N, Sun LH

R eferences 1. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics 2009 update: a report from AHA Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009;119:e21-e181. 2. Wren C, Reinhardt Z, Khawaj K. Twenty year trends in diagnosis of life-threatening neonatal cardiovascular malformations. Arch Dis Child Fetal Neonatal Ed. 2008;93:F33-F35. 3. Bradshaw EA, Cuzzi S, Kiernan SC, Nagel N, Becker JA, Martin GR. Feasibility of implementing pulse oximetry screening for congenital heart disease in a community hospital. J

References [1] LI, J. WEBB - PANDIELLA, C. - CAMPBELL, G. M.: Discrete particle motion on sieves–a numerical study using the DEM simulation, Powder Technology, Vol. 133, No. 1 – 3, 2003, pp. 190 – 202. [2] LIU, K. S.: Some factors affecting sieving performance and efficiency, Powder Technology, Vol. 193, No. 2, 2009, pp. 208 – 213. [3] WANG, G. - TONG, X.: Screening efficiency and screen length of a linear vibrating screen using DEM 3D simulation, Mining Science and Technology (China), Vol. 21, No. 3, 2011, pp. 451 – 455. [4] ZHAO, L. - ZHAO, Y. - LIU, C. - LI, J